Peter Martin

11PUBLICATIONS
90CO-AUTHORS
Liquid biopsiesRespiratory diseasesPredictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 02, 2025
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma.

Matthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly

|Oct 07, 2025
Adaptation and Performance of the Self-Report-Generated Charlson Comorbidity Index in the Lymphoma Epidemiology of Outcomes (LEO) Cohort.

James R Cerhan, Tereza Sokolova, Elliott J Cahn

|Sep 23, 2024
Acalabrutinib alone or in combination with rituximab for follicular lymphoma: An open-label study.

Paolo Strati, Rebecca Champion, Morton Coleman

|Oct 06, 2023
XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.

Rossella Marullo, Sarah C Rutherford, Maria V Revuelta

|Jul 05, 2022
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials.

Sarah C Rutherford, Jun Yin, Levi Pederson

|Jun 28, 2022
Treatment Outcomes and Roles of Transplantation and Maintenance Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma: Results From Large Real-World Cohorts.

Peter Martin, Jonathon B Cohen, Michael Wang

Pageof 2

Frequent Collaborators

4 joint publications

Brad S Kahl

3 joint publications

Sarah C Rutherford

3 joint publications

James R Cerhan

3 joint publications

Brian K Link